Depressed classical complement pathway activities in chronic lymphocytic leukaemia
- PMID: 4017286
- PMCID: PMC1577204
Depressed classical complement pathway activities in chronic lymphocytic leukaemia
Abstract
Haemolytic activities of the classical and alternative complement pathways, and levels of C1, C4, C3, factor B and C1 inhibitor (C1-INH) were measured in 85 serum samples from 46 patients with chronic lymphocytic leukaemia (CLL). Significantly decreased mean C1 and C4 levels were found, and the haemolytic activities of these components were low or low normal in more than 50% of the sera tested. In 15 sera from 5 patients a complement profile characteristic of acquired C1-IHN deficiency was observed. These results indicate that the depression of the activity of the classical complement pathway is a frequently occurring feature in CLL.
Similar articles
-
Repressed classical complement pathway activities and clinical correlations in chronic lymphocytic leukaemia.Acta Med Hung. 1986;43(4):389-95. Acta Med Hung. 1986. PMID: 3601584
-
Acquired C1-esterase inhibitor deficiency and recurrent herpes infection in a patient with chronic lymphocytic leukemia.Diagn Immunol. 1983;1(2):68-71. Diagn Immunol. 1983. PMID: 6680094
-
Prevention of immune precipitation by purified classical pathway complement components.Clin Exp Immunol. 1984 Nov;58(2):486-92. Clin Exp Immunol. 1984. PMID: 6333948 Free PMC article.
-
Control of immune complexes by the classical pathway.Behring Inst Mitt. 1989 Jul;(84):111-20. Behring Inst Mitt. 1989. PMID: 2529842 Review.
-
[The course of acquired C 1 esterase inhibitor deficiency in lymphoproliferative syndrome].Ann Med Interne (Paris). 1988;139(7):488-90. Ann Med Interne (Paris). 1988. PMID: 3072895 Review. French.
Cited by
-
A case report of pre-eclampsia-like endothelial injury in the kidney of an 85-year-old man treated with ibrutinib.BMC Nephrol. 2022 Jul 23;23(1):264. doi: 10.1186/s12882-022-02873-w. BMC Nephrol. 2022. PMID: 35870899 Free PMC article.
-
Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia.Front Immunol. 2021 Oct 25;12:738915. doi: 10.3389/fimmu.2021.738915. eCollection 2021. Front Immunol. 2021. PMID: 34759921 Free PMC article. Review.
-
Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system.Ann Rheum Dis. 1991 Oct;50(10):713-6. doi: 10.1136/ard.50.10.713. Ann Rheum Dis. 1991. PMID: 1958096 Free PMC article.
-
Aspects of C1-inhibitor biochemistry and pathophysiology.Clin Rheumatol. 1987 Sep;6(3):332-9. doi: 10.1007/BF02206831. Clin Rheumatol. 1987. PMID: 3327641 Review.
-
How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application.Front Immunol. 2020 Oct 29;11:593610. doi: 10.3389/fimmu.2020.593610. eCollection 2020. Front Immunol. 2020. PMID: 33193442 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous